PRU
62
2
BWA
53
-7
GIS
58
-2
NFLX
40
3
MMC
53
-5
PSA
35
-11
CAH
63
3
AES
47
-3
SYY
45
-3
FE
48
-4
TJX
53
-9
AMG
77
3
QCOM
45
2
THC
47
2
HSY
43
2
SYF
74
5
FSLR
73
15
PNR
51
3
NDAQ
74
4
KMB
31
-11
PRU
62
2
BWA
53
-7
GIS
58
-2
NFLX
40
3
MMC
53
-5
PSA
35
-11
CAH
63
3
AES
47
-3
SYY
45
-3
FE
48
-4
TJX
53
-9
AMG
77
3
QCOM
45
2
THC
47
2
HSY
43
2
SYF
74
5
FSLR
73
15
PNR
51
3
NDAQ
74
4
KMB
31
-11
Financhill
Back

First Trust Smith Opportunistic Fixed Income ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
28

FIXD
First Trust Smith Opportunistic Fixed Income ETF

Last Price:
$44.31
Seasonality Move:
0.28%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
28
First Trust Smith Opportunistic Fixed Income ETF (FIXD) is a Sell

Is First Trust Smith Opportunistic Fixed Income ETF a Buy, Sell or Hold?

  • The current First Trust Smith Opportunistic Fixed Income ETF [FIXD] share price is $44.31. The Score for FIXD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • FIXD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FIXD Stock Price Chart

What is First Trust Smith Opportunistic Fixed Income ETF's stock price today?

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

FIXD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 44.64 Sell
Chaikin Money Flow: -217215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.3 - 44.58) Sell
Bollinger Bands (100): (44.08 - 44.72) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

FIXD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.31 Sell
20-day SMA: 44.44 Sell
50-day SMA: 44.56 Sell
200-day SMA: 43.95 Buy
8-day EMA: 44.32 Sell
20-day EMA: 44.4 Sell
50-day EMA: 44.45 Sell
200-day EMA: 44.11 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

First Trust Smith Opportunistic Fixed Income ETF Earnings Growth & FIXD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

First Trust Smith Opportunistic Fixed Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):